Presynaptic imidazoline receptors mediate inhibition of noradrenaline release from sympathetic nerves in rat blood vessels
暂无分享,去创建一个
[1] G. Molderings,et al. Presynaptic imidazoline receptors and non‐adrenoceptor[3H]‐idazoxan binding sites in human cardiovascular tissues , 1997, British journal of pharmacology.
[2] R. Martı́n-Ruiz,et al. Agmatine does not have activity at α 2-adrenoceptors which modulate the firing rate of locus coeruleus neurones: an electrophysiological study in rat , 1996, Neuroscience Letters.
[3] P. Soubrié,et al. Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain. , 1996, Life sciences.
[4] K. Fink,et al. α2‐Adrenoceptor‐Independent Inhibition by Imidazolines and Guanidines of Noradrenaline Release from Peripheral, but Not Central Noradrenergic Neurons , 1995, Annals of the New York Academy of Sciences.
[5] D. Kendall,et al. Comparison of the interaction of agmatine and crude methanolic extracts of bovine lung and brain with α2‐adrenoceptor binding sites , 1995, British journal of pharmacology.
[6] P. Soubrié,et al. Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist. , 1995, Life sciences.
[7] P. Ernsberger,et al. Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors. , 1995, The Journal of pharmacology and experimental therapeutics.
[8] D. Reis,et al. Agmatine: an endogenous clonidine-displacing substance in the brain. , 1994, Science.
[9] P. Ernsberger,et al. A second generation of centrally acting antihypertensive agents act on putative I1-imidazoline receptors , 1992 .
[10] C. Raper. ADRENOCEPTOR CLASSIFICATION , 1987, Clinical and experimental pharmacology & physiology.
[11] K. Starke. Presynaptic α-autoreceptors , 1987 .
[12] K. Starke. Presynaptic alpha-autoreceptors. , 1987, Reviews of physiology, biochemistry and pharmacology.
[13] M. Sonders,et al. 1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[14] K. Starke. α-Adrenoceptor subclassification , 1981 .
[15] K. Starke. Alpha-adrenoceptor subclassification. , 1981, Reviews of physiology, biochemistry and pharmacology.
[16] R. Furchgott. The Classification of Adrenoceptors (Adrenergic Receptors). An Evaluation from the Standpoint of Receptor Theory , 1972 .